Market Closed - Swiss Exchange 12:30:06 2025-03-17 pm EDT 5-day change 1st Jan Change
128.00 CHF +1.75% Intraday chart for Medacta Group SA -0.78% +20.08%

Medacta Posts Lower FY22 Attributable Profit

March 17, 2023 at 02:31 am EDT
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
Already a customer? Log In
mtnewswires logo
© MT Newswires - 2023
Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta Mar. 07 MT
Medacta Group Finalizes Purchase of Parcus Medical Mar. 07 MT
Medacta Group SA acquired Parcus Medical, LLC from Anika Therapeutics, Inc.. Mar. 06 CI
Swiss stocks - Factors to watch on February 13 Feb. 13 RE
Medacta Group SA, 2024 Earnings Call, Feb 04, 2025 Feb. 04
Medacta Group Logs Higher Preliminary FY24 Revenue Feb. 04 MT
Medacta Group SA Reports Unaudited Group Revenue Results for the Year Ended 31 December 2024 Feb. 04 CI
Swiss Market Index Advances Ahead of SNB's Rate Decision Day 24-09-25 MT
Medacta Group SA - Analyst/Investor Day 24-09-25
Medacta Group Reports Growth in H1 Attributable Profit, Revenue 24-09-25 MT
Medacta's Profitability at Risk Amid Expected Sales Slowdown in H1, Morgan Stanley Says 24-09-24 MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2024 24-09-23 CI
Medacta Group, Think Surgical Partner in US for Robotic Total Knee Arthroplasty Solution 24-08-30 MT
Medacta Group, Mighty Oak Medical Settle Patent Dispute via New License Deal 24-08-28 MT
Medacta Group SA, H1 2024 Earnings Call, Jul 25, 2024 24-07-25
Medacta Group SA Provides Earnings Guidance for the Year 2024 24-03-13 CI
Medacta Group SA, 2023 Earnings Call, Mar 13, 2024 24-03-13
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2023 24-03-12 CI
Medacta Enters Collaboration for RFID Technology in Healthcare Business 24-02-20 MT
Medacta Group SA, 2023 Sales/ Trading Statement Call, Feb 02, 2024 24-02-02
Medacta Group Books 17% Jump in FY23 Revenue 24-02-02 MT
Medacta to Expand Swiss Facilities to Boost Production Capacity 23-11-30 MT
Medacta Group to Launch Optimized Knee Implant 23-10-30 MT
Medacta's New Study Shows Accuracy of NextAR Shoulder Application 23-10-13 MT
Medacta Group SA, Q2 2023 Earnings Call, Sep 22, 2023 23-09-22
Chart Medacta Group SA
MOVE: Dynamic Chart
Logo Medacta Group SA
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
Employees
1,826
More about the company
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
133.09EUR
Average target price
153.30EUR
Spread / Average Target
+15.18%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MOVE Stock
  4. News Medacta Group SA
  5. Medacta Posts Lower FY22 Attributable Profit